 MONMOUTH JUNCTION, N.J. and BOLOGNA, Italy, Aug. 30, 2021 PRNewswire -- CytoSorbents Corporation NASDAQ: CTSO and Aferetica srl Italy, two pioneers in intensive care immunotherapy and blood purification, announce the commercial launch of Afereticas PerLifeTM ex vivo organ perfusion system for kidney and liver transplant and CytoSorbents PerSorbTM adsorber, based on the CytoSorbents ECOS-300CYTM sorbent technology to remove inflammatory mediators during ex vivo organ perfusion, at the European Society of Organ Transplantation ESOT Congress in Milan, Italy from August 29 September 1, 2021. 